Kanzhun

BZ · NASDAQ

$16.46+$0.05 (+0.30%)TodayMarket closed ·
Prev close $16.41

Latest news

  • Press releaseGlobe Newswire

    KANZHUN LIMITED Declares Annual Cash Dividend and Shareholder Return Plan

  • Press releaseGlobe Newswire

    BOSS Zhipin Reports Accelerated Second-Quarter Growth and Strengthened Shareholder Returns

  • NewsBamboo Works

    Kanzhun Eyes Brazil, Argentina And Vietnam For Growth

  • NewsAvi Kapoor

    Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday

  • News

    Transcript: Kanzhun Q2 2026 Earnings Conference Call

  • Press releaseGlobe Newswire

    KANZHUN LIMITED Declares Annual Cash Dividend

  • News

    Kanzhun Q2 Adj. EPS $0.33 Beats $0.29 Estimate, Sales $353.510M Miss $355.280M Estimate

  • Press releaseGlobe Newswire

    KANZHUN LIMITED Announces Second Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB2.06 Billion in 1H2026

  • Press releaseGlobe Newswire

    BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.99 Billion in 2026

  • Press releaseGlobe Newswire

    BOSS Zhipin's Ongoing Share Repurchases Reach Nearly RMB1.94 Billion in 2026

  • Press releaseGlobe Newswire

    BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.83 Billion in 2026

  • Press releaseGlobe Newswire

    BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.76 Billion in 2026

  • News

    Kanzhun Q1 2026 Earnings Call: Complete Transcript

  • News

    Kanzhun Q1 Adj. EPS $0.27 Beats $0.22 Estimate, Sales $299.911M Miss $302.370M Estimate

  • News

    Earnings Scheduled For May 20, 2026

  • NewsTim Melvin

    Alpha Buying: Brilliance Capital and the Discipline of Long-Term China Investing

  • News

    Kanzhun Q4 Adj. EPS $0.27 Beats $0.25 Estimate, Sales $297.225M Miss $298.940M Estimate

  • Press releaseGlobe Newswire

    KANZHUN LIMITED Announces Fourth Quarter and Full Year 2025 Financial Results

  • News

    A Preview Of Kanzhun's Earnings

  • News

    Insights Ahead: Kanzhun's Quarterly Earnings

  • Press releasePRNewswire

    Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

  • NewsLekha Gupta

    Chinese Stocks Dominate Mid Cap Space - Bilibili And XPeng Are Among Top 7 Mid Cap Gainers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?

  • NewsAvi Kapoor

    Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday

  • NewsThe Bamboo Works

    Kanzhun Works Investors Into Selling Frenzy With Talk Of 'Challenging Times'

  • NewsAvi Kapoor

    Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday

  • NewsAvi Kapoor

    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

  • NewsAvi Kapoor

    Tesla Posts Weak Earnings, Joins Visa, Deutsche Bank And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Top 3 Tech And Telecom Stocks That Are Set To Fly In July

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.